CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
GlaxoSmithKline plc Company Snapshot
GlaxoSmithKline plc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares GlaxoSmithKline plc with three other pharmaceutical manufacturers in Europe: Novartis AG of Switzerland (2018 sales of 51.94 billion Swiss Francs [US$52.25 billion] of which 66% was Innovative Medicines), Sanofi S.A. of France (35.68 billion Euro [US$40.04 billion] of which 69% was Pharmaceuticals), and Bayer AG which is based in Germany (39.59 billion Euro [US$44.43 billion] of which 42% was Pharmaceuticals & Biological Products).

Sales Analysis. During the year ended December of 2018, sales at GlaxoSmithKline plc were £30.82 billion (US$38.96 billion). This is an increase of 2.1% versus 2017, when the company's sales were £30.19 billion. This was the fourth straight year of sales growth at GlaxoSmithKline plc. Sales of Vaccines saw an increase that was more than double the company's growth rate: sales were up 14.2% in 2018, from £5.16 billion to £5.89 billion. Not all segments of GlaxoSmithKline plc experienced an increase in sales in 2018: sales of Consumer Healthcare fell 1.2% to £7.66 billion. GlaxoSmithKline plc also experienced decreases in sales in Pharmaceuticals (down 0.0% to £17.27 billion) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
GlaxoSmithKline plc
  Stock Performance Chart for GlaxoSmithKline plc
 
  Stock Data: Recent Stock Performance:
  Current Price (6/21/2019): 1,576.40p
(Figures in Pounds Sterling)
1 Week -0.5%   13 Weeks -0.4%  
4 Weeks 1.4%   52 Weeks 2.0%  
 
GlaxoSmithKline plc Key Data:
  Ticker: GSK Country: United Kingdom
  Exchanges: DUS FRA LON OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 30,821,000,000
(Year Ending Jan 2019).
Employees: 95,490
  Currency: Pounds Sterling Market Cap: 77,605,080,579
  Fiscal Yr Ends: December Shares Outstanding: 4,922,930,765
  Share Type: Ordinary Closely Held Shares: 53,358,189
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.